Boxs Herbals Seagreens Relief
Out of date information, search anotherSUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Napiers Ascovita
Box's Herbals Seagreens Relief
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
360 mg of Kelp thallus (Ascophyllum nodosum L. (Le Jolis) or Ascophyllum canaliculatum L. (Kuntze))
Each tablet contains 50 mg of lactose and 100 mg of sucrose (see section 4.4 ‘Special warnings and precautions for use.’)
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Coated tablet, round.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
A traditional herbal medicinal product used for the relief of rheumatic or muscular pain, and general aches and pains in the muscles and joints, based on traditionally use only.
4.2 Posology and method of administration
For oral use only.
Adults and the elderly: Take one tablet three times a day.
If symptoms worsen or do not improve after 4 weeks a doctor or a qualified healthcare practitioner should be consulted.
4.3 Contraindications
Hypersensitivity to the active ingredients or iodine or to malt or to any of the excipients.
Patients with thyroid disorder.
4.4 Special warnings and precautions for use
Do not exceed the stated dose.
The use in children under 18 years of age is not recommended because data are insufficient and medical advice should be sought.
Do not take with any medicines or dietary supplements containing iodine.
If symptoms worsen or do not improve after 4 weeks a doctor or a qualified healthcare practitioner should be consulted.
If articular pain accompanied by swelling of the joint, redness or fever are present, a doctor should be consulted.
This product contains lactose and sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
4.5 Interaction with other medicinal products and other forms of interaction
No interaction studies have been performed.
Do not take with any medicines or dietary supplements containing iodine.
Do not take with medicines for thyroid disorders.
4.6 Fertility, pregnancy and lactation
The safety of this product during pregnancy and lactation has not been established. In the absence of sufficient data the use of this product during pregnancy and lactation is not recommended.
Studies on the effect on fertility have not been performed.
4.7 Effects on ability to drive and use machines
No studies on the effects on the ability to drive or operate machines have been performed.
4.8 Undesirable effects
None known.
If adverse reactions occur, a doctor or qualified health care practitioner should be consulted.
4.9 Overdose
No cases known.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.
5.2 Pharmacokinetic properties
Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.
5.3 Preclinical safety data
Tests on reproductive toxicity, genotoxicity and carcinogenicity have not been performed.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Malt Extract
Sucrose
Maltodextrin
Lactose
Talc
Magnesium Stearate Pre-gelatinised Starch Aniseed Oil.
6.2 Incompatibilities
Not known.
6.3 Shelf life
3 years
6.4 Special precautions for storage
Do not store above 25°C. Store in the original container.
6.5 Nature and contents of container
Glass bottle with a Bakelite type screw-cap closure, packed in a cardboard carton: 50, 100, 150 and 200 tablets.
Not all pack sizes may be marketed.
6.6 Special precautions for disposal
There are no special precautions for disposal.
7 MARKETING AUTHORISATION HOLDER
Rickard Lane’s and W. H. Box Ltd 24 Tennant Street Edinburgh EH6 5ND
8 MARKETING AUTHORISATION NUMBER(S)
THR 15670/0050
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
26/03/2013
10 DATE OF REVISION OF THE TEXT
26/03/2013